Delivery Order SPE2DB20D3103-SPE2DB23FN8S3
Award Date
6/30/23
Potential Completion Date
7/3/23
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of 4,559,396,849 units of Losartan Potassium 50 mg tablets to the Defense Logistics Agency (DLA). The $9,875.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which runs through December 31, 2025. The...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHVD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,318.69, is for the delivery of 4,567,235,577 units of Losartan Potassium 50 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,016,626 units of Losartan Potassium 50 mg tablets. The contract has a ceiling value of $1,071.94 and a period of performance through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 with a...
This federal contract award is for the delivery of 4,564,996,243 units of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $6,355.23 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 25, 2024, with a completion date of June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083 firm-fixed-price delivery order is for the supply of 4,564,015,207 units of Losartan Potassium 50 mg tablets. The contract has an ultimate completion date of March 20, 2024 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,387.15, is for the delivery of 4,559,643,285 units of Losartan Potassium 25 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of January 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,743.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,555,540,832 units of Losartan Potassium 100 mg tablets, with an ultimate completion date of November 30, 2021. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $12,274.42, is for the delivery of 4,566,914,687 units of Losartan Potassium 50 mg tablets. This is a Firm Fixed Price Delivery Order contract with a performance period that runs through January 14, 2025. The contract was awarded on January 13, 2025 and was not set aside for any...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,450.90, is a delivery order for the supply of Losartan Potassium 50 mg Tablets in 1,000-count packages. The contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,677,679 units of Losartan Potassium 50 mg tablets. The $1,996.04 firm fixed price delivery order has an ultimate completion date of April 24, 2023 and was awarded on April 21, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...